Viemed Healthcare, Inc. (VMD) stock
Close on Nov 11, 2026Market cap $347.75MP/E 24.0Yield –
Viemed Healthcare, Inc. grew revenue 21.8% to $310.37M over the twelve months to Sep 30, 2026. Operating income rose 14.6% to $24.09M, moving the operating margin from 8.3% to 7.8%. Free cash flow was $21.38M, up 297.0% from a year earlier. At the latest close the market valued the company at $347.75M, 24.0 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $347.75M
- P/E ratio
- 24.0
- Price to sales
- 1.12
- Price to book
- 2.32
- Dividend yield
- –
- Free cash flow yield
- 6.15%
Fundamentals
- Revenue
- $310.37M
- Net income
- $15.62M
- EPS, diluted
- $0.38
- Free cash flow
- $21.38M
- Book value per share
- $3.64
- Diluted shares
- 41M
Trading
- Next earnings
- Mar 3, 2027 (estimated, during market hours)
- Previous close
- $8.98
- Open
- $8.98
- Day's range
- $8.98 – $9.15
- Volume
- 190,989
- Average volume (20 days)
- 216,848
- Index membership
- Russell 2000 (since Jun 2023), Russell 3000 (since Aug 2023)
- Beta (5 years)
- 0.58
- 52-week range
- $6.18 – $12.61
- RSI (14 days)
- 44.4
- Volatility (1 year)
- 40.9%
- Relative volume
- 0.61×
- WACC
- 7.7%
On 2 of our idea lists: Institutions accumulating, Fallen quality
Index membership is inferred from the holdings of funds that track each index (IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2019, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | VMD | S&P 500 | Difference | VMD per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -4.1% | -2.4% | −1.7 pts | ||
| 3 months | -1.6% | -1.2% | −0.5 pts | ||
| Year to date | +22.9% | +12.3% | +10.6 pts | ||
| 1 year | +43.8% | +12.4% | +31.3 pts | ||
| 3 years | +27.9% | +78.8% | −50.9 pts | +8.5% | +21.4% |
| 5 years | +58.8% | +75.2% | −16.4 pts | +9.7% | +11.9% |
Nine years at a glance
Fiscal years 2017 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Viemed Healthcare filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Update
- Results
- Results
About Viemed Healthcare
Services-Misc Health & Allied Services, NEC
Viemed Healthcare, Inc. supplies home medical equipment and post-acute clinical care services, primarily focusing on respiratory therapy, chronic disease management, and women's health. The company provides medical devices largely through rental arrangements, including invasive and non-invasive home ventilators, continuous positive airway pressure units, oxygen therapy equipment, and percussion vests. Additional offerings include home sleep apnea testing, lactation supplies such as breast pumps, and clinical recruitment services. Its client base consists of patients managing chronic illnesses like chronic obstructive pulmonary disease and neuromuscular disorders at home, along with healthcare institutions seeking supplemental clinical personnel.
Company profile, executives and historyViemed Healthcare stock: common questions
What is Viemed Healthcare's stock price?
VMD closed at $9.13 on Nov 11, 2026, up 1.67% on the day. Over the past 52 weeks it traded between $6.18 and $12.61.
What is Viemed Healthcare's market cap?
Viemed Healthcare was worth $347.75M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is VMD's P/E ratio?
VMD trades at 24.0 times earnings, based on diluted earnings per share of $0.38 over the twelve months to Sep 30, 2026.
How much revenue does Viemed Healthcare make?
Viemed Healthcare reported revenue of $310.37M for the twelve months to Sep 30, 2026, up 21.8% from a year earlier.
Does Viemed Healthcare pay a dividend?
No. Viemed Healthcare has not paid a cash dividend over the last twelve months.
When does Viemed Healthcare report earnings next?
Viemed Healthcare is expected to report Q4 FY2026 results on Mar 3, 2027, during market hours. The date is estimated from its past reporting pattern until the company confirms it.
How has VMD stock performed over the past year?
Including dividends, VMD returned +43.8% over the past year, against +12.4% for the S&P 500.
How many VMD shares are sold short?
2M shares were sold short at the latest FINRA report, 4.68% of the float, or 8.5 days of average trading volume.
Who are Viemed Healthcare's competitors?
Companies most similar to Viemed Healthcare by business, industry and size include PGNY, TCMD, SHC, AHCO, OMDA.
See a number that looks wrong?